Chronic Thromboembolic Pulmonary Hypertension (CTEPH) is a debilitating and potentially fatal condition caused by unresolved blood clots in the pulmonary arteries. While extensive registries exist for North American and European populations, there has been a significant "data desert" regarding CTEPH in the Middle East and North Africa (MENA) region. This study presents the first long-term registry of CTEPH in the United Arab Emirates (UAE), tracking patients over a seven-year period at a tertiary referral center in Abu Dhabi.
The Clinical Landscape of CTEPH
CTEPH is unique among forms of pulmonary hypertension because it is potentially curable through a complex surgical procedure known as pulmonary thromboendarterectomy (PTE). However, the clinical characteristics, age of onset, and response to therapy can vary significantly by region. Understanding these local nuances is critical for optimizing patient care and resource allocation.
Methodology
Researchers at Cleveland Clinic Abu Dhabi conducted a retrospective study of 39 consecutive adult patients diagnosed with CTEPH between January 2015 and April 2022. Diagnosis followed standardized protocols, including right heart catheterization (RHC), ventilation-perfusion (V/Q) scans, and CT angiography.
For the final analysis, 37 patients were included and divided into two cohorts:
- Surgical Group (n=12): Patients who underwent PTE.
- Medical Group (n=25): Patients treated with vasodilator drugs.
During the study period, PTE was not yet available locally in the UAE. Consequently, surgical candidates were referred to international centers of excellence in the United States, United Kingdom, Austria, and France. Medical therapy involved a stepwise escalation from monotherapy—typically riociguat—to dual and triple combination therapies.
Key Findings: The "Youth Factor"
One of the most striking findings of the registry is the median age of the UAE cohort: 46 years. This is nearly two decades younger than the mean age reported in European registries, which typically hover around 68 years. This suggests a different clinical profile in the Gulf region, potentially driven by genetic predispositions, environmental risk factors, or earlier clinical presentation.
Demographically, the cohort was predominantly female (68%) and Emirati (62%).
Treatment Outcomes and Survival
The study highlights a stark contrast between surgical and medical outcomes:
- Survival Rates: The surgical group achieved a 100% survival rate at the 1-, 3-, and 5-year marks. In contrast, the medical group saw survival rates of 86.4% at one year, dropping to 68% at three and five years.
- Functional Improvement: The surgical group showed statistically significant improvements in WHO Functional Class (p=0.008) and NT-proBNP levels (p=0.04). Most surgical patients were able to discontinue all vasodilator medications post-operatively.
- Risk Stratification: By the final follow-up, 75% of the surgical group met "low-risk" criteria according to the Simplified French model, compared to only 16% of the medical group.
- Medical Escalation: The medical group required aggressive intervention, with 25% of patients escalating to triple therapy. This rate is significantly higher than the 2% reported in some European registries, indicating a more rapid disease progression or a more severe baseline state in this cohort.
Socioeconomic Barriers to Care
A critical insight from this registry is the impact of socioeconomic factors on clinical outcomes. Six patients were identified as surgical candidates but were unable to undergo PTE due to a lack of financial support or insurance coverage for international travel. This highlights a significant gap in healthcare delivery for specialized surgical needs and underscores the necessity of localizing advanced treatments.
Limitations and Future Directions
The study is limited by its retrospective nature and a relatively small sample size, which may affect the statistical power of subgroup comparisons. Additionally, because surgeries were performed at various international institutions, the results reflect a range of surgical expertise rather than a single UAE standard of care.
However, the landscape is shifting. The recent establishment of a local PTE program at Cleveland Clinic Abu Dhabi is expected to increase the number of patients receiving curative surgery. Future research will focus on the outcomes of this local program, providing a more controlled look at CTEPH management within the UAE's own healthcare infrastructure.
Conclusion
This first UAE registry confirms that CTEPH in the region affects a significantly younger population than in the West. While medical management remains a challenge with a 68% five-year survival rate, surgical intervention offers excellent outcomes. The transition toward localizing PTE surgery is a vital step in overcoming socioeconomic barriers and improving the long-term prognosis for CTEPH patients in the Gulf.
Summary updated